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One of the critical gaps in malaria transmission biology
and surveillance is our lack of knowledge about Plasmo-
dium falciparum gametocyte biology, especially sexual
dimorphic development and how sex ratios that may in-
fluence transmission from the human to the mosquito.
Dissecting this process has been hampered by the lack of
sex-specific protein markers for the circulating, mature
stage V gametocytes. The current evidence suggests a
high degree of conservation in gametocyte gene comple-
ment across Plasmodium, and therefore presumably for
sex-specific genes as well. To better our understanding of
gametocyte development and subsequent infectiousness
to mosquitoes, we undertook a Systematic Subtractive
Bioinformatic analysis (filtering) approach to identify sex-
specific P. falciparum NF54 protein markers based on a
comparison with the Dd2 strain, which is defective in
producing males, and with syntenic male and female pro-
teins from the reanalyzed and updated P. berghei (related
rodent malaria parasite) gametocyte proteomes. This pro-
duced a short list of 174 male- and 258 female-enriched P.
falciparum stage V proteins, some of which appear to be
under strong diversifying selection, suggesting ongoing
adaptation to mosquito vector species. We generated an-
tibodies against three putative female-specific gameto-
cyte stage V proteins in P. falciparum and confirmed ei-
ther conserved sex-specificity or the lack of cross-
species sex-partitioning. Finally, our study provides not
only an additional resource for mass spectrometry-de-
rived evidence for gametocyte proteins but also lays
down the foundation for rational screening and develop-
ment of novel sex-partitioned protein biomarkers and
transmission-blocking vaccine candidates. Molecular &
Cellular Proteomics 13: 10.1074/mcp.M114.040956, 2705–
2724, 2014.
Sexual stages represent only a small fraction of Plasmo-
dium falciparum parasites that are present during human ma-
laria infection, yet they alone are responsible for disease
transmission (1). As such, the Malaria Eradication Research
Agenda (malERA) has prioritized the need for studies that
specifically address these transmission stages, with the hope
of developing new transmission-blocking vaccines and drugs,
as well as diagnostics that are specific for these sexual stages
(2–4). In fact, one of the critical gaps in malaria transmission
biology and surveillance centers on the lack of knowledge
about the infectivity of symptomatic and asymptomatic ga-
metocytemic individuals for mosquitoes. Many infected indi-
viduals harboring the Plasmodium falciparum sexual stage, or
gametocyte, are asymptomatic carriers and they represent
the primary reservoir for malaria transmission (5). Missing the
opportunity to treat these carriers will increase the risk for
epidemic malaria in regions that have approached the elimi-
nation phase. Thus, proper surveillance of gametocyte carri-
ers is critical for evaluating ongoing malaria control and elim-
ination programs. Surveillance is difficult, however, because
gametocytes comprise only 0.1–2% of the total body parasite
load during active infection (5), and are only observed in the
bloodstream in their mature (Stage V) form, with the first four
developing stages sequestered in tissues. Microscopy-based
analysis for sex ratio determination and infectivity studies
remains limited because of cost, training, and suitability for
population-wide studies. Although light microscopy remains
the gold standard for malaria diagnosis, the relatively low
prevalence of circulating gametocytes makes it difficult to
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accurately detect much less quantify these stages. Moreover,
because of variations in skill level of microscopists and incon-
sistency in method, exclusive use of light microscopy esti-
mates of gametocyte carriage carries a high risk of error.
Importantly, the presence of stage V gametocytes in the
bloodstream alone, as determined by thick smear microscopy
does not imply infectivity to mosquitoes. Ratios of male and
female gametocytes in the blood circulation are skewed to-
ward the female, but they can vary significantly based on
co-infection, parasite and gametocyte density, and host en-
vironmental factors (6), and it is therefore hypothesized that
this variation in sex ratios will influence mosquito infectivity.
For example, mature gametocyte sex ratios can change dur-
ing the course of infection in response to host cues or espe-
cially following antimalarial treatment resulting in an increase
in the number of males (6, 7). However, it remains unknown
whether the transmission potential to mosquitoes of the indi-
viduals in these studies fluctuated because of the changes in
sex ratio.
There are currently no uncomplicated tools to distinguish
male and female mature P. falciparum gametocytes (of which
at least one of each is required for fertilization and ookinete
development in the mosquito) at the molecular level. Although
the proteome of Plasmodium gametocytes has been de-
scribed (8–11), these previous analyses fell just short of pro-
viding the partitioned male and female proteomes for P. fal-
ciparum. Moreover, the availability of the genomes of human,
primate, and rodent malaria parasites and the acquisition of
sequence information for recent field isolates of P. falciparum
have created the opportunity to understand gene diversity
and conservation in sexual stage development across Plas-
modia. Identifying markers that differ between male and fe-
male P. falciparum stage V gametocytes is critical in informing
transgenic approaches aimed at separating the two. It has
been argued that the inherent evolutionary differences be-
tween rodent and human malaria parasites, especially for the
sexual stages, limit the utility of the P. berghei gametocyte
proteome (11) in providing a priori knowledge of these mark-
ers. Several iterations and improvements to the P. berghei
genome have been made available since 2005, whereas MS
search engines have improved commensurately, further com-
pounding the issue. However, we would also argue that the
current evidence suggests a high degree of conservation in
gametocyte gene complement across Plasmodium (12, 13),
and therefore presumably in sex-specific genes - despite key
differences such as gametocyte sequestration and morphol-
ogy. Here, we report on our effort to address these scientific
gaps to a certain extent and to test our gametocyte gene
conservation hypothesis through the use of comparative pro-
tein bioinformatics analyses of the mature stage V gameto-
cyte proteomes of two distinct P. falciparum strains with our
update of the bioinformatic analysis of the P. berghei male
and female gametocyte proteomes.
MATERIALS AND METHODS
Parasite Culture and Gametocyte Isolation—
P. falciparum NF54 Gametocyte Culture—P. falciparum gameto-
cytes were cultured in RPMI 1640 containing HEPES and glutamine
and supplemented with 10% human serum and hypoxanthine as
described earlier (14). P. falciparum NF54 strain was diluted to 0.5%
mixed stage asexual parasites and 4% hematocrit in complete culture
medium in six well plates. Plates were transferred to a 37 °C incubator
and microaerophilic environment was created using desiccators can-
dle jar. Media was exchanged every day without the addition of new
blood from day one to day 17 (culture maturation). To remove asexual
stage parasites 50 mM N-acetylglucosamine was added to the culture
media from day eight (early stage gametocytes) until day 10. Blood
smears were made every alternate day to monitor the progress of the
culture and to determine gametocytemia on day 18. Stage V game-
tocytes were harvested from culture at day 17 postgametocytogen-
esis initiation and isolated by passage through a LS-25 Midi MACS
column (CS Miltenyi). Synchronized trophozoite cultures that were
used for Western blot analyses were generated from a recently
thawed stabilate and harvested at 48 h post treatment of the mixed
asexual culture with 5% sorbitol.
P. falciparum Dd2 Gametocyte Culture—The production of stage V
gametocytes was performed using a modified version of a previously
described protocol (15). Ten (10) ml cultures at 4% hematocrit and
5% ring parasitemia were sorbitol synchronized. After 24 h, tropho-
zoite cultures were transferred to a T75 flask to which complete media
and red blood cells were added to create a 30 ml culture with 2%
hematocrit in each flask. After another 24 h, adding 50% old media
and 50% new complete media stressed the newly reinvaded rings.
Cultures were allowed to develop to late schizonts and then split into
three T75 flasks evenly. Twenty (20) mLs of fresh media was then
added to each flask. During sexual stage development, fresh media
was added daily. At 48 h after invasion of a mixture of asexually and
sexually committed merozoites, 1 ml of 1 M N-Acetyl-D-Glucosamine
was added to all flasks in order to clear asexual parasites. Drug
treatment was given during media changes for three consecutive
days. On day nine of sexual development, the cultures were MACS
column separated to purify late stage gametocytes. Purified cultures
were washed in PBS and snap frozen. Preparation of the synchro-
nized trophozoite protein lysate for Western blot analyses is as de-
scribed above for NF54.
Protein Extraction—The GiRBC1 eluate from the MACS column
was washed with cold PBS three times prior to protein extraction. The
freeze-thaw method was applied to extract the soluble proteins by
adding 120 l 5 mM phosphate buffer containing 0.5 mM PMSF, 1 mM
EDTA, and 1 mM protease inhibitors mixture (Sigma, St. Louis, MO) to
1  106 GiRBC pellets. A total of four freeze-thaw cycles were used.
The supernatant was collected as the soluble protein fraction after
centrifugation at 20,000  g for 30 min at 4 °C. To get the membrane
proteins, the pellet was washed with cold PBS for three times prior to
being dissolved in 95 l SDT-lysis buffer composed of 4% (w/v) SDS,
100 mM Tris/HCl, and 0.1 M DTT, pH 7.6, and then boiled at 95 °C for
5 min. The supernatant was collected as the membrane protein
fraction after centrifugation at 20,000  g for 5 min at 4 °C.
Multi-Lane Combined In-gel Digestion (MLCID)—We used a Multi-
Lane Combined In-gel Digestion (MLCID) strategy to reduce the im-
1 The abbreviations used are: GiRBC, gametocyte infected red
blood cell; GcV, gametocyte stage V; Asx, asexual blood stages;
SCX, strong cation exchange; ppm, parts per million; FA, formic acid;
PSMA, PepArML Search MASPECTRAS 2 Analysis; Pb, Plasmodium
berghei; Pf, Plasmodium falciparum; SSB, Systematic Subtractive
Protein Bioinformatic analysis.
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pact of nonspecific absorption during the process of in-gel tryptic
digestion and to avoid losing SDS-PAGE separation power. For NF54
parasites, we used three lanes for the soluble protein fraction and four
lanes for the membrane fraction, respectively, and each lane was
loaded with 20 l of sample under reducing conditions. After resolv-
ing on a 4–20% precast gradient gel (BioRad, Hercules, CA), the
proteins were stained with Coomassie. GiRBC soluble and membrane
fractions were cut into 14 slices by combining three lanes (soluble)
and 16 slices by combining four lanes (membrane). Both the soluble
and membrane fractions from Dd2 were cut into 14 slices by combing
three lanes. Gel slices were cut into 1  1 mm pieces prior to
de-staining, reduction and alkylation, tryptic digestion and peptide
extraction. The extracted peptides were lyophilized and then resus-
pended in 2% acetonitrile, 97.9% water, and 0.1% formic acid buffer
for LC-MS/MS analysis.
LC-MS/MS—Biological in-gel digestion replicates were analyzed
independently as follows. One third of the MLCID sample of all the
fractions, were injected onto an Agilent LC-MS system comprised of
a 1200 LC system coupled to a 6520 Q-TOF via an HPLC Chip Cube
interface. The only exception to this process was made for the first
low molecular weight fraction, which consisted primarily of hemoglo-
bin, and only 1/50th of this fraction was injected. The sample was
trapped and analyzed using an Agilent Polaris-HR-Chip-3C18 chip
(360 nL, 180 Å C18 trap with a 75 m i.d., 150 mm length, 180 Å C18
analytical column). Peptides were loaded onto the enrichment column
automatically by autosampler using 97% solvent A (0.1% formic acid
in water) and 3% solvent B (0.1% formic acid in 90% acetonitrile) at
a flow rate of 2 l/min. Elution of peptides from the analytical column
was performed using a gradient starting at 97% A at 300 nL/min. The
mobile phase was 3–10% B for 4 min, 10–35% B for 56 min, 35–99%
for 2 min, and maintained at 99% B for 6 min, followed by re-
equilibration of the column with 3% B for 10 min. Data dependent
(autoMS2) mode was used for MS acquisition by Agilent 6520 Q-TOF
at 2 GHz. Precursor MS spectra were acquired from m/z 315 to 1700
and the top 4 peaks were selected for MS/MS analysis. Product
scans were acquired from m/z 50 to 1700 at a scan rate of 1.5/
second. A medium isolation width (4 amu) was used, and a collision
energy of slope 3.9 V/100 Da with a 2.9 V offset was applied for
fragmentation. A dynamic exclusion list was applied, with precursors
excluded of 0.50 min after two MS/MS spectrum was acquired.
Mass Spectrometry Data Search and Analysis—Each sample was
further fractionated into 14 membrane and 14 soluble fractions. Raw
data from Dd2 sample runs (two biological replicates, 217,165
MS/MS total spectra) and NF54 GiRBC sample runs (three biological
replicates, 497,006 MS/MS total spectra) was converted to mzXML
format using Trapper (Institute for Systems Biology, Seattle, Wash-
ington). A merged search was performed on the mzXML data for each
fraction using the PepArML metasearch engine (16), which automat-
ically conducts target and decoy searches using the following: Mas-
cot (17), OMSSA (18), and Tandem (19) with native, K-score (20) and
S-score pluggable scoring modules (21), and Inspect (22) with MS-GF
spectral probability scoring (23). The results were then combined
using an unsupervised machine-learning strategy, and the peptide
identification false discovery rates (FDR) were estimated using iden-
tifications from the reversed decoy searches (24).
The data was searched by a combined database of SwissProt
Human and Plasmodium falciparum sequences from GeneDB
(2013.02), which consists of 28,960 entries with the following param-
eters; fixed modification: carbamidomethyl cysteine and variable
modification: oxidized methionine; mass tolerance: 30 ppm and 20
ppm respectively for precursor and fragment ions; one missed cleav-
age. The results from the metasearch were combined and the results
were parsed into the MASPECTRAS 2 data analysis system (25) with
data filters of 1% spectra FDR and 5% peptide FDR, and protein
identifications were then clustered to remove redundancy. Proteins
were clustered together if there was a peptide identification shared
between them, because this indicates substantial sequence similarity,
and the protein with the greatest number of peptides identified was
considered the unique protein identification from that group.
Throughout this paper we report only the unique identifications. Pro-
teins identified by single peptides were manually validated. The data
analysis pipeline meets all MIAPE standards (26) and the proteomics
data have been deposited in the ProteomeExchange via the PRotein
IDEntifications database (PRIDE) partner repository with the data set
identifier PXD000813 (27). The protein lists have also been uploaded
to PlasmoDB (plasmodb.org).
For the reanalysis of the Khan et al. data set (11), the individual MS
raw files from Male (113,213 total MS/MS spectra) and Female data
set (243,468 total MS/MS spectra) were searched against a combined
database of SwissProt Human, Mouse, and P. berghei. Using these
results we determined the male/female partitioned proteomes for P.
falciparum gametocytes through a subtractive bioinformatics pro-
teomics approach. Briefly, in our approach, we take protein identifi-
cation lists and use set comparisons to generate protein lists that are
enriched for biological states, with those protein lists clustered to
remove redundancy. Therefore, we took the NF54 and Dd2 gameto-
cyte-infected red blood cell lysate proteome and subtracted out all
host proteins, generating the NF54 and Dd2 gametocyte proteomes.
Putative male-specific, female-specific, and sex-unspecific pro-
teomes were generated by taking protein identifications unique to
NF54 and Dd2, respectively. These putative proteomes were then
BLAST searched against the two previous data sets of Khan et al. and
Silvestrini et al. (8, 11).
Identified proteins were annotated by GeneDB (02, 2013); specifi-
cally, the Gene Ontology database was searched by BLAST homol-
ogy for annotations. The surface expressed (S.E.) proteins were pre-
dicted by searching for canonical signal peptides with the SignalP 4.1
Server (28). Transmembrane domain information was obtained on all
identified proteins by the transmembrane protein prediction tool
TMHMM Server v. 2.0 (29).
Analysis of Diversity and Divergence for Male- and Female-enriched
P. falciparum Gametocyte Proteins—The SNP N diversity statistic,
representing mean pairwise nonsynonymous SNP diversity per site,
was calculated for previously generated data within each genic region
for a given population using the VCFtools-site-pi utility (30). For each
pair of populations, the Fst divergence statistic was calculated for
each gene with the VCFtools implementation of Fst and weighted Fst
estimators as described in Weir and Cockerham (31).
Expression of Recombinant Proteins and Generation of Polyclonal
Antibodies for Proteomic Validation—The selection of predicted im-
munogenic domains for each protein were based on physiochemical
properties of each gene (PF3D7_0906100; PF3D7_1218800;
PF3D7_0309100; and PF3D7_0422000) using the Bcepred server (32)
and Immune epitope Database (IEDP) (33). Each codon-optimized
gene or gene fragment (GenScript) was used as a template for PCR
along with the following primer sets (all 5 to 3): PF3D7_0906100,
F-CACCATGGGTAACAAAATTAGC, R-TTTCAGGTTTTTGATACGT-
TCC; PF3D7_1218800, F-CACCAAAATCGTGCTGTCCA, R-ACCGA-
AGTAAATAAAACTCGGTTC; PF3D7_0309100, F-CACCGACCT-
GAGCGGCCT, R-CAGTTCTTCGTTTTTGATGAACACG. Each 20 l
PCR reaction consisted of 0.25 l of DNA (200 ng/l), 4.0 l of 5x
iProof DNA polymerase buffer, 0.4 l of dNTPs (10 mM each), 0.4 l
each of forward and reverse primers (10 M), 0.1 l of iProof DNA
polymerase (2 U/l), and 14.85 l of sterile deionized water. Reaction
conditions were 98 °C for 2 min, followed by 40 cycles of 98 °C for
15 s, 62 °C for 25 s, and 72 °C for 25 s. All forward primers were
appended with the nucleotides CACC on the 5 end to facilitate
directional insertion of each amplicon into the E. coli expression
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vector pBAD202/D-TOPO. Ligation and transformation steps were
carried out according to the manufacturer’s protocols, and clones
were grown on selective LB agar plates with kanamycin (50 g/ml)
overnight at 37 °C. For each gene, colonies were picked and
screened by PCR and then sequenced to confirm proper orientation
and reading frame. Prior to induction, positive clones were grown in
LB media  kanamycin (50 g/ml) overnight at 37 °C in a shaking
incubator (200 RPM). Each overnight culture was then used to seed
50 ml of fresh LB  kanamycin (50 g/ml), grown to an O.D.600 
0.4, and then induced with arabinose (0.01%) for 6 - 8 h at 37 °C.
Cells were harvested by centrifugation at 10,000  g for 10 min, and
the presence of recombinant protein from each expression was con-
firmed by Western blot using mouse anti-His monoclonal Ab (Sigma).
The cell pellets were then processed for recombinant protein using
BugBuster Reagent (EMD Millipore, Billerica, MA) following the man-
ufacturer’s protocol for both soluble and insoluble fractions. Recom-
binant protein was then purified by immobilized metal affinity chro-
matography (ProBond, Invitrogen, Carlsbad, CA) following the
manufacturer’s “hybrid” protocol for inclusion bodies and the “native”
protocol for soluble protein. Following elution from the column, elu-
ates positive for protein by Western blot were pooled and dialyzed
overnight (3500–10,000 Da MWCO) against imadozole-free elution
buffer and then concentrated using diafiltration (3000 Da MWCO).
To generate polyclonal antibodies, Swiss Webster mice were im-
munized with purified recombinant protein emulsified with incomplete
Freund’s adjuvant (Sigma) following a prime and three boosts at two
week intervals. The mice were exsanguinated at the end of the im-
munization regimen to collect serum.
Immunofluorescence Microscopy Assays—P. falciparum NF54 ga-
metocyte and trophozoite samples were fixed with 4% paraformal-
dehyde/0.0075% glutaraldehyde and prepared for fluorescence mi-
croscopy by washing three times with PBS. The cells were
permeabilized with 0.2% Triton-X 100/PBS for 10 min and then
washed as before. After washing, samples were blocked with 3%
BSA in PBS overnight at 4 °C. The samples were then incubated with
mouse antigametocyte protein serum (1:50) for 1 h at RT. Cells were
washed with PBS as before and detected with Alexa Fluor(R) 488
Goat Anti-mouse IgG (HL), highly cross-adsorbed (Molecular
Probes®, 1:1000) in 0.02% Evans blue for 1 h at RT. Following
incubation, the cells were washed three times with PBS, resuspended
in PBS, spotted on slides and allowed to air dry. Samples were
mounted using Slow Fade Gold antifade reagent with DAPI (Molecular
Probes, Eugene, OR) or Aqua Poly/mount (Polysciences Inc., War-
rington, PA). Samples were imaged using a Nikon Upright E800
microscope equipped with SPOT camera and software and a Nikon
90i light microscope (Nikon Corp., Tokyo, Japan) connected to a
Hamamatsu ORCA high sensitivity monochrome CCD camera.
RESULTS
The Plasmodium falciparum Stage V Gametocyte Pro-
teome: NF54 versus Dd2—We selected two P. falciparum
strains for proteomic analysis of stage V gametocytes: a
transmission-competent reference isolate, NF54 (West Africa)
(34) and a Southeast Asian clone Dd2 (35). Importantly, Dd2
has a defect in male gametocyte development resulting in
arrested male stages of rectangular and teardrop shape that
are usually not found in culture. The genetic basis of this
defect is at least in part a mutation in the male development 1
(MDV-1) gene (36). Assuming that the stage V proteome of
Dd2 will be enriched for female proteins, we can then char-
acterize the male- and female-enriched P. falciparum pro-
teomes by comparative analysis of Dd2 and NF54.
We produced three biological replicates of P. falciparum
(NF54 isolate) stage V gametocytes in the presence of GlcNAc
to block asexual replication at the onset of gametocytogen-
esis and therefore ensure pure Stage V gametocyte popula-
tions at the day of collection, that is, 17 days post initiation
of gametocytogenesis. Microscopic analysis of thin-blood
smears from the day 17 culture suggested a predominantly
stage V culture (6–7% gametocytemia), with few stage IV
gametocytes and a sex ratio of 1:4 for male versus female
(Fig. 1A, Table I). In parallel, we cultured the P. falciparum Dd2
mutant clone and induced gametocytogenesis in the pres-
ence of GlcNAc to produce two biological replicates of pref-
erentially female-enriched stage V (day 17) gametocyte sam-
ples. We determined by microscopy the number of prestage V
gametocytes in two replicate cultures with low and high ga-
metocytemias to be 14.5% and 27.3% , respectively (Table II).
The proportion of male gametocytes that are arrested devel-
opmentally and with altered morphology (35), were 0.6% and
1.2%, respectively, for the teardrop forms and 0.4% and
1.6%, respectively, for the rectangular forms. Although far
fewer in number these arrested male stages 1–4 were con-
sidered a potential source of contaminating male proteins.
We demonstrated highly consistent acquisition of the
mixed-sex stage V gametocyte proteome (Fig. 2A, supple-
mental Table S1), with greater than 95% reproducibility in pro-
tein identifications across biological replicates (Fig. 2A–2B). We
identified 1703 mature NF54 stage V proteins, including all the
known and well-studied gametocyte surface markers such as
P230, P48/45, P47, and the LCCL domain-containing (CCp)
protein family of molecules [Table I, supplemental Table S1A;
reviewed in reference (37)]. Of these, 449 (26%) proteins were
consistently and exclusively identified in the membrane fraction
of each sample. In parallel, a total of 1337 proteins were iden-
tified reproducibly from the two Dd2 biological replicates (Table
II, supplemental Table S1B). Of these, 726 (54%) proteins were
identified consistently and exclusively in the membrane fraction
of each sample. For both NF54 and Dd2 it remains unclear if
these proteins localize to the parasite plasmalemma or RBC
membrane. We observed that NF54 and Dd2 have 1105 pro-
teins in common (supplemental Table S1C), 598 NF54-enriched
proteins (supplemental Table S1D), and 232 Dd2-enriched pro-
teins (supplemental Table S1E), which may include proteins
emanating from the malformed, arrested male gametocytes
(Table II). We compared our NF54 gametocyte stage V pro-
teome (1703 proteins), which will be referred to in the text as
DTgV, with the published P. falciparum 3D7/NF54 gametocyte
stage V proteomes, gametocyte stage I-II and trophozoite pro-
tein lists (8), the data sets of which we refer to in our study here
on as FSgV (2031 proteins, supplemental Table S1F), FSgI-II
(1427 proteins, supplemental Table S1G), and FS Asx (1345
proteins, supplemental Table S1H), respectively. For these three
data sets, we converted the previous and now obsolete acces-
sion numbers for each protein to the new protein identifiers as
described in the P. falciparum 3D7 databases in GeneDB (Ver-
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sion 3) and PlasmoDB (Version 9.3. 11 Mar 11, 2013). The NF54
stage V proteome was comparable to the 3D7/NF54 gameto-
cyte stage V proteome (8), with 1274 proteins found to be in
common between the two NF54 data sets. We also noted the
addition of 429 NF54 proteins to the gametocyte proteome (Fig.
2D). Therefore, we conclude that these two data sets represent
the most complete P. falciparum NF54 stage V-enriched game-
tocyte proteome to date. The Dd2 stage V proteome was also
comparable to the FSgV proteome, with 1106 proteins in com-
mon (Fig. 2E). Similar to the results with our NF54 stage V
comparison, we noted that 230 Dd2-enriched proteins had
partitioned from FSgV. The acquisition of the NF54 and Dd2
stage V gametocyte proteomes (summary MS statistics are
provided in Table III) represents the first step in our Systematic
Subtractive Protein Bioinformatics analysis (SSB) approach,
which is outlined in Fig. 1C.
Re-analysis of the Rodent Malaria Sex-specific Pro-
teomes—To define and characterize the subset of con-
FIG. 1. Proteomic and bioinformatic strategy to sex-partition Plasmodium falciparum stage V gametocyte proteins. A, Gameto-
cyte sex ratios were determined using differential staining and microscopy. Improved R66 Giemsa is diluted 1:40 in Sorensen buffer (pH
7.2) and used to stain a methanol-fixed, thin smear of stage V (mature) gametocytes from a gametocyte culture. Gametocytes can be
differentiated according to five classical parameters (35, 55) as well as by differential Giemsa staining patterns. Males (M) appear pink with
no distinct nucleus and females (F) appear blue with a distinct nucleus. B, Proteomics workflow. Soluble and membrane proteins were
extracted for Multi-Lane Combined In-gel Digestion (MLCID, see methods) prior to Chip-based nano-HPLC MS/MS analysis. C,
Bioinformatics workflow. LC MS/MS data from NF54 and Dd2 is searched on PepArML meta search engine with six search engines. P.
berghei MS/MS male proteome and MS/MS female proteome is also uploaded to PepArML and Maspectras2. The result is combined in
PepArML by unsupervised machine learning and stored in Maspectras2 and queried for analysis. Proteome results are then compared with
the P. berghei MS/MS male proteome and MS/MS female proteome as shown (refer to supplemental Fig. S1 for additional detail). This
comparison is done by orthologous protein matches and a subtractive bioinformatics approach (see Methods), producing partitioned
proteomes for male and female gametocytes.
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served male and female Plasmodium gametocyte markers,
we sought to compare the Dd2 and NF54 data with the
available male and female proteomes from the rodent ma-
laria parasite, P. berghei ANKA 2.34 (11) (see Fig. 1C for the
strategy). However, given the number of iterations of the P.
berghei genome since 2005, as well as further refinement of
MS search engines capabilities, we first performed a Pep-
ArML-Search MASPECTRAS2 Analysis (PSMA) of the orig-
inal peptide spectral data from that study, to allow for
appropriate and updated comparisons of protein identities
(25, 38).
Our re-analysis resulted in updated P. berghei male (1128
clustered proteins) and female (1180 clustered proteins) ga-
metocyte proteomes (Table IV, supplemental Table S2A, 2B).
From these two data sets we identified 762 clustered proteins
(Fig. 2F) that were common between male and female game-
tocytes, as compared with the 51 shared proteins reported
between berghei males and females (11). The re-analyzed
(PSMA) sex-specific protein lists increased from 278 to 366
male proteins (Fig. 2G, supplemental Table S2D) and from 171
to 418 female proteins (Fig. 2H, supplemental Table S2E). We
found that only 136 proteins were conserved between the
original and current male-specific protein lists (Table 2F) and
70 proteins between the original and current Female-specific
protein lists (Table 2G). Taken altogether, the combined data
sets represent the most complete ANKA sex-specific game-
tocyte proteomes to date.
Apart from the increased resolution of the data set through
the use of the PSMA approach, we also noted that seven
proteins that were described previously to be male-specific
(11), actually partitioned to the PSMA female-specific protein
list and that two proteins that were reported initially to be
female-specific were now found to be in the PSMA male-
specific list (Table V, supplemental Table S2H). We also ob-
served that several proteins were putatively shared between
males and females in the current PSMA analyses with differ-
ential enrichments in one sex over the other (Table VI, sup-
plemental Table S2I).
Importantly, two proteins that were highlighted [cf. original
Table I in (11)] as male-specific based on separation of ga-
metocytes expressing GFP under the control of a sex-specific
promoter, the Dynein heavy chain (PBANKA_092540) and
Dynein heavy chain (PBANKA_041610) retained the same
partitioning (supplemental Table S2A-E). The 6-cysteine pro-
tein, P230p (PBANKA_030600), was described previously to
be male-specific and we find this to hold true following PSMA
re-analysis as well. There were two proteins, the transmis-
sion-blocking vaccine candidate, P48/45 (PBANKA_135960)
and the male development gene 1 (PBANKA_143220), which
were not reported previously in the original proteomic study of
P. berghei gametocytes, but following PSMA, we noted that
these two previously described male-specific proteins (39, 40)
were indeed present in the original raw data set and in our
reanalysis did not exhibit sex-specific partitioning. Further
interrogation of the data suggests that P48/45 appear to be
enriched (3.25-fold based on spectral counts) in P. berghei
males as opposed to females (supplemental Table S6). Inter-
estingly, despite its name, male development gene 1 (MDV1)
appeared to be less enriched in males as opposed to females
based on our PSMA reanalysis, which is consistent with the
report by Lal et al., (2009), wherein it was shown that MDV1 is
in both males and females but is particularly important for
female gametocyte development in the rodent malaria para-
site (41). Although it was shown recently that the egress of
male gametes is partly dependent on MDV1 (42). We also
noted that a dynein heavy chain protein (PBANKA_050730)
that did not partition to either sex appears to have a 74.5-fold
enrichment in males. Conversely, we also determined that
another dynein heavy chain protein (PBANKA_021400) ap-
pears to be enriched 67-fold in females. A kinesin
(PBANKA_145880), which has not been fully described to
date, was enriched 36-fold in the male fraction. The CCp1/
LCCL1 domain containing protein (PBANKA_130070), which
was hypothesized to be female-specific (37, 43), was also
TABLE I
Microscopic verification of the Stage V gametocyte male-to-female
ratio for the Plasmodium falciparum NF54 used in this study. Several
thin-smear slides taken from each N-acetylglucosamine (GlcNAc)
treated culture of NF54 used for MS analysis was examined by oil-
immersion microscopy (1000X) at day 17 post-initiation of gametocy-
togenesis by 1/40 dilution of Giemsa in Sorensen’s buffer. Reads 1–3
correspond to biological replicates
Read 1 Read 2 Read 3 Pooled
Total # RBCs counted 1204 1212 1130 3546
Number of males (pink) 16 15 17 48
Number of females (blue) 88 58 40 186
Total # gametocytes (Stage V) 104 73 57 234
Gametocytemia (Stage V) 0.09 0.06 0.05 0.07
Male/Female Ratio 0.18 0.26 0.43 0.26
TABLE II
Microscopic verification of purified Pre- and Mature Stage V gameto-
cytes for the Plasmodium falciparum Dd2 line used in this study. The
Dd2 clone has a defect in male gametocyte development (35). How-
ever, the presence of Pre-Stage V gametocytes would complicate the
partitioning of Dd2 proteins because male-specific markers in P.
falciparum, for example, alpha-tubulin II are expressed in pre-stage V
females. In addition to determining the number of prestage V’s we
also ascertained the number of “tear drop” and “rectangular” forms,
which have been hypothesized to be malformed male gametocytes
(35). The contamination level with prestage V as well as these mal-
formed parasites helped explain our Dd2 gametocyte proteome
Gametocytemia
HIGH LOW
Total # RBCs counted 536 758
Number of stage V (female) 354 425
Number of prestage V 138 73
Number of arrested male: Rectangular 8 2
Number of arrested male: Teardrop 6 3
Total # Gametocytes 506 503
Gametocytemia (%) 94.4 66.3
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found in both male and female fractions, but was 63-fold
enriched in the male fraction. The osmiophilic body protein
(PBANKA_146300), a putative female-specific protein was
found in both male and female fractions and is 27-fold en-
riched in the female fraction. These sex-specific enrichments
are significant and support the notion that while MS sensitivity
enables their detection in the fraction, these fractions are
likely unable to identify completely male- or female-specific
proteins. However, evidence from the literature is derived
from both P. berghei and P. falciparum studies, and it remains
to be seen whether falciparum-specific expression and sex-
partitioning mirrors that of P. berghei.
We anticipated differential partitioning following PSMA, be-
cause we had also observed that a direct comparison of the
FIG. 2. Summary of protein identifications from the reanalysis of Plasmodium berghei ANKA 2. Summary of protein identifications from
the reanalysis of Plasmodium berghei ANKA 2.34 Male and Female Gametocyte Proteomes and the current Stage V Plasmodium
falciparum gametocyte proteomes for the NF54 isolate and Dd2 strain. Reproducibility of the analyses of the P. falciparum NF54 samples is
shown. Three biological replicates for P. falciparum NF54 preparations were analyzed by MS. The 1090 proteins identified from analysis of all
replicates were considered for statistical analysis. A, Peptides per identified protein for each biological replicate B, and spectra per identified protein
for each biological replicate. Normalized peptide count and spectral count were analyzed by one-way ANOVA with Geisser-Greenhouse correction
method. Average values are plotted with error bars of 95% CI. C, P. falciparum NF54 and Dd2 protein identification. There were 1105 proteins in
common between 1703 Pf NF54 and 1337 Pf Dd2 total protein identification at 1% spectra FDR (minimum one unique peptide for a protein, see
methods for single peptide validation details) and 5% peptide FDR for a protein. We observed that 598 proteins partitioned to the NF54 samples
and 232 proteins to the Dd2samples. D–E, Proteins found in common between the NF54 orDd2 protein lists and the FSgV data set (8). We observed
that 74% NF54 and 82% of the Dd2 proteins were proteins were present in the Silvestrini gametocyte stage V data set (8). F, Male and Female P.
berghei protein identification following the PSMA re-analysis of the published data set (11). Out of 1546 total unique protein identification 762
proteins were in common between P. berghei PSMA Male and P. berghei PSMA Female at 1% spectra FDR (minimum one unique peptide for a
protein, see methods for single peptide validation details) and 5% peptide FDR for a protein. We found that 366 proteins were specific for male P.
berghei and 418 proteins were P. berghei female-specific. G, A comparison of PSMA Male with the original ANKA-Male protein list found only 136
proteins in common between the two data sets.H, A comparison of PSMA Female with the original ANKA-Female protein list found only 70 proteins
in common between the two data sets.
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Pb PSMA lists with the published Pb sex-specific lists re-
sulted in only 136 shared male-proteins (Fig. 2E and supple-
mental Table S2H) and only 70 shared female-proteins (Fig.
2H and supplemental Table S2I). Moreover, we observed that
there are 100 proteins from the original male-specific
(ANKA-M) data set (278 proteins) that are also found in the
PSMA conserved male and female proteins (762 proteins). We
could therefore account for only 178 male proteins of the
original 278 male-specific proteins. In addition to the 70
shared female-specific proteins, we found that 85 proteins
from the original female-specific (ANKA-F) data set were also
in the PSMA conserved male and female protein list (762
proteins). We could therefore account for only 86 female-
enriched proteins of the original 171 female-specific proteins.
Altogether, re-analysis of the available P. berghei mature ga-
metocyte proteome data by PSMA has significantly deepened
the analysis of this data set. We used this new annotation for
comparison with the P. falciparum NF54/Dd2 stage V pro-
teome data.
Systematic Subtractive Protein Bioinformatics Analysis
(SSB) to Partition Male and Female Stage V Gametocyte Pro-
teomes—To define the male and female proteomes of P.
falciparum stage V gametocytes we employed a SSB work-
flow using the re-analyzed P. berghei mature gametocyte
proteome data as a reference (Fig. 1C, supplemental Fig. S1).
This approach is based on the fundamental assumption that
sexual development is conserved evolutionarily across the
genus, although not all proteins will sex-partition similarly
between the different lineages. Thus, the re-analyzed P. ber-
ghei male/female gametocyte PSMA data sets along with the
proteome of a mutant P. falciparum clone, Dd2, which is
defective in mature male gametocyte development, permit the
sex-partitioning of our mixed-sex NF54 stage V gametocyte
proteome. At this juncture, it is important to note that because
we are using a bioinformatic approach that is contingent on
successful protein identification employing our specific meth-
odology and instrumentation (see Methods), we refer to all
male and female protein classifications in our analysis as
“male- or female-enrichments.” However, we refer to the sex-
specific proteomes generated by Khan et al., (11) and includ-
ing our PSMA proteomes as “male/female-specific” and the
stage-specific proteomes assembled by Silvestrini et al., (8)
as “stage X-specific” protein lists, because these were pro-
duced independently and the categorizations are well-sup-
ported. Furthermore, integral in this process is use of known
or well-supported P. falciparummale/female gametocyte pro-
teins as positive control markers (e.g. P47). This will allow us
to track their partitioning throughout the SSB workflow (Fig.
3B–3G, supplemental Fig. S1A–S1C), as described below.
Step 1—We curated the Dd2 proteome by first identifying
Dd2 proteins that are conserved in the male P. berghei PSMA
Male data set and generating a new list of male-subtracted
proteins, that is, Dd2 female-enriched proteins (Dd2-FE; 1258
proteins). The male proteins that are shared with Dd2 are set
aside (Dd2-M; 79 proteins) (Fig. 3B, supplemental Table
S3A–S3B).
Step 2—This set was then combined with the mixed-sex
protein list from NF54 to identify proteins that are conserved
between Dd2-FE and NF54 and are likely to be enriched in
female- proteins (Dd2-FE/NF54; 1045 proteins; Fig. 3C, sup-
plemental Table S3C1). The proteins that are excluded from
the overlap are then used to generate a list of likely NF54
male-enriched proteins (NF54-ME; 658 proteins) and Dd2-FE-
specific proteins (Dd2-FE-SP; 213 proteins) (Fig. 3C, supple-
mental Table S3C2).
Step 3—The NF54-ME protein list is then used to search
the P. berghei male-specific gametocyte protein list (PSMA
TABLE III
Mass spectrometry data summary statistics for P. falciparum NF54
and Dd2 stage V gametocytes. *783 proteins are shared between
membrane and soluble NF54 proteins and *621 proteins are shared
between Dd2 membrane and soluble proteins. **1105 proteins are
shared between Dd2 and NF54 proteins
Strain
Total #
spectra
# Unique
spectra
Unique proteins
identified
P. falciparum NF54
Membrane fraction 97,128 96,167 1455
Soluble fraction 87,308 86,390 1031
Total NF54 184,436 182,557 1703*
P. falciparum Dd2
Membrane fraction 80,127 36,064 1065
Soluble fraction 77,364 49,184 893
Total Dd2 157,491 85,248 1337*
Combined total 341,927 267,805 1935**
TABLE IV
Comparative mass spectrometry data summary statistics. Summary of
the re-analyses of the Plasmodium berghei ANKA 2.34Male and Female
Gametocyte Proteomes using an updated P. berghei genome database
(version 2013–01) and the PepArML Search-MASPECTRAS2 Analysis
(PSMA) platform (25, 38)
Total #
spectra
# Unique
peptide
Unique proteins
identified
P. berghei MALE
Previousa – – 650
Currentb 30,786 9389 1128
P. berghei FEMALE
Previous – – 541
Current 41,719 9465 1180
MALE enriched
Previous – 698 278
Current 5076 2158 366
FEMALE enriched
Previous – 216 171
Current 3405 1359 418
Shared Male/Female
Previous – 758 69
Current 64,024 10,407 762
a Search engine used in previous analyses: Mascot (11).
b Search engine used in current analyses: Mascot, OMSSA, X!Tan-
dem, Kscore, Sscore, Inspect and MyriMatch.
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Male; 366 proteins) to identify orthologs by BLAST (Fig. 3D).
P. falciparum NF54 proteins with syntenic matches in the male
P. berghei list are likely to be genus conserved and NF54 male
specific candidates (NF54-M; 155 proteins). The NF54-ME
proteins that do not have matches are likely to be NF54-
specific proteins (NF54-SP; 503 proteins, supplemental Table
S3F1).
Step 4—The Dd2-FE/NF54 (1045) protein list was used to
search the P. berghei female-specific gametocyte protein list
(PSMA Female; 418 proteins) to identify orthologs by BLAST.
This analysis identified 181 proteins conserved between the
two data sets, and 864 proteins that are Dd2-FE/NF54-spe-
cific (supplemental Table S3F2) and 237 proteins that are
specific to P. berghei females (Fig. 3E).
Step 5—The NF54-ME list (male-enriched, 658 proteins)
was used to determine if there are proteins that are conserved
with the PSMA Female (418 proteins) list. We were surprised
to find 60 proteins that are conserved between PSMA Female
and the putative male-enriched NF54-ME protein subset (sup-
plemental Table S3G). Following the comparison, we noted
that 598 proteins are likely to be enriched with candidate
male-partitioning P. falciparum proteins (supplemental Table
S3H).
Although we did not anticipate missing proteins that do not
partition to each of the subsequent protein lists, we nonethe-
less performed a set of additional data filtering steps as
follows:
● Determine if There are Any Overlapping Proteins between
NF54 F (181 Proteins) and PSMA Male (366 Proteins)—This
filtering step was performed to ensure that we had not as-
signed erroneously a female protein that was actually found in
the PSMA Male list. As expected no overlapping proteins
were observed (data not shown).
● Determine the Overlap between Dd2-M or “M1” Protein
List (79 Proteins) and the NF54-M or “M2” Protein List (155
Proteins) to Assess Dd2 versus NF54 Specific Protein Sub-
sets—We observed 60 conserved proteins between these two
lists (Supplemental Table S3I), and these conserved proteins
represent the putative P. falciparum-specific male gameto-
cyte proteins. Proteins that are conserved between the two
P. falciparum lines that have diverged both geographically
and phylogenetically (44) were categorized as conserved P.
falciparum male proteins (conserved Pf-M; 60 proteins).
Interestingly, 19 proteins were found to be specific to only
Dd2 (Dd2-M-SP) and 95 proteins were NF54-specific
(NF54-M-SP).
● Determine if There are Proteins that are Conserved
between NF54-M or “M2” List (Male-specific Candidates,
155 Proteins) and the PSMA Female (Female, 418 Proteins)
List—The NF54-M list was predicted to be highly male-
partitioned and we observed, as we had expected in this
quality check of the data, no overlap with P. berghei female
proteins.
● Determine if There are Proteins That are Conserved be-
tween NF54-SP (503 Proteins) with the PSMA Female (418
Proteins) List—We identified 60 proteins, and these were set
aside and categorized as NF54-SP-female proteins (NF54-
SP-F) for subsequent inclusion in the berghei-driven female-
enriched protein list. The remaining 443 proteins, which were
not shared with Dd2 or present in the P. berghei data set,
were considered NF54-specific proteins, nonsex partitioning
(or potentially P. falciparum male-specific) (Fig. 3F, supple-
mental Table S3J).
● Determine if There are Proteins That are Conserved be-
tween Dd2-FE-SP (213 Proteins) and the PSMA Female (418
Proteins) List—We identified 17 female proteins that appear to
be completely Dd2-specific (Dd2-SP) in our analysis (Fig. 3G,
supplemental Table S3K). Because we expected that all of the
Dd2-FE-SP were gametocyte female-enriched proteins, we
hypothesized that the remaining 196 proteins from this list are
Dd2-specific, non-(sex) partitioning.
● Determine if There are Proteins That are Conserved be-
tween Dd2-FE/NF54 (1045 Proteins) and PSMA Male (366
Proteins) List?—As expected, we did not identify any contam-
inating males in this protein list because, in theory, the
Dd2-FE is female enriched and thus any matching proteins
TABLE V
A PSMA reanalysis of the existing Plasmodium berghei male and female gametocyte proteome using the current iteration of the genome
revealed significant changes in the assignment of male and female proteins
Previous Current
Acc. number Protein description M F M F
PBANKA_050450 Cytoplasmic dynein intermediate chain, putative ● ●
PBANKA_080230 Ubiquitin transferase, putative ● ●
PBANKA_090620 Conserved Plasmodium protein, unknown function ● ●
PBANKA_093990 U6 snRNA-associated Sm-like protein LSm4, putative
(LSM4)
● ●
PBANKA_103870 Conserved Plasmodium protein, unknown function ● ●
PBANKA_113640 Conserved Plasmodium protein, unknown function ● ●
PBANKA_120490 Conserved Plasmodium protein, unknown function ● ●
PBANKA_123400 Vacuolar ATP synthetase, putative ● ●
PBANKA_141440 Exportin-T, putative ● ●
 See reference (11).
 PepArML-Search MASPECTRAS2 Analysis (PSMA) (38, 39).
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from the mixed NF54 gametocyte stage V proteome, should
be female-enriched (data not shown).
The systematic steps described above allowed us to as-
semble a list of putative cross-strain (NF54-Dd2) P. falciparum
male (Pf-M) and female (Pf-F) stage V gametocyte protein
lists. Our initial Pf-M list, which was a grouping of NF54-M and
Dd2-M proteins, identified 174 proteins; whereas our Pf-F list,
which was a grouping of NF54-F, Dd2-SPF, and NF54-SPF
proteins, identified 258 proteins. Of note there were marked
differences in the composition of the Pf-M and Pf-F protein
lists from either NF54 or Dd2, with the latter contributing only
11% of the proteins for Pf-F and 33% of the proteins for Pf-M.
Partitioning of Male- and Female-enriched Gametocyte Pro-
teins in P. falciparum
Pf-MALES—Of those described to be male specific in P.
berghei (11), we noted that the Mitogen-activated protein
kinase 2 (MAP2; PF3D7_1113900), the Dynein light chain type
2 (PF3D7_1114000) were also only found in the male pro-
teome in P. falciparum (supplemental Table S4A). The or-
tholog of the second P. berghei dynein heavy chain
(PF3D7_0905300), which was described to be male-specific
as well, was found to be nonsex partitioning. The 6-cysteine
protein, P230p (PF3D7_0208900), which was described pre-
viously to be male-specific in P. berghei and confirmed by our
PSMA analysis was also found to be male-enriched in P.
falciparum. The same was noted for the NIMA-related kinase
1 (NEK1; PF3D7_1228300), which was also male-enriched
in P. falciparum. The ortholog of the P. cynomolgi and P.
vivax sperm-specific protein Don Juan (PF3D7_1413200)
was found to be a male-specific candidate. This protein was
not found in the FS Asx and FSgI-II databases, although
Florens et al., (2002) detected successfully the protein in
highly synchronized trophozoites (9). One of the top male-
partitioning proteins in P. berghei (PBANKA_050730) (11)
was detected in our total NF54 gametocyte stage V pro-
teome but the ortholog (PF3D7_1023100) did not partition
to either sex. PBANKA_050730 was already found to be
shared in berghei males and females so it would naturally
not partition in P. falciparum, because the male- and fe-
male-specific berghei lists were used to guide the assembly
of the male and female lists in P. falciparum.
Pf-FEMALES—Our data set supports the argument that
both the NIMA related kinase-4 (NEK4, PF3D7_0719200) and
LCCL/CCp3 (PF3D7_1407000) proteins are conserved be-
tween P. berghei and P. falciparum female gametocytes (sup-
plemental Table S4B). We also noted that NIMA related kinase
2 (NEK2, PF3D7_0525900) partitioned to females. A functional
NEK2 has been shown to be essential for human/murine
parasite development in the mosquito and its expression ap-
pears to be enriched in female gametocytes (45). The ortholog
of the P. berghei female-specific (11) Dynein heavy chain
(PF3D7_0729900) did not partition to either sex. Interestingly,
P28, which is expressed as a transcript in gametocytes and
only translated during gametogenesis, was identified in the
female proteome. Although there are clear differences in the
conditions of gametocyte cultures as opposed to in vivo de-
velopment, which may lead to the misexpression of P28 pro-
tein, it is also possible that female gametocyte activation may
have occurred during cell harvest. Our data however, sup-
ports the current hypothesis that P28 is female-specific.
Approximately 46% of the 299 proteins (138) are conserved
proteins with unknown function and represent a rich set of
potential female markers for subsequent study.
We then took the Pf-M (174 proteins) and Pf-F (258 pro-
teins) proteomes that were generated above to identify pro-
teins that are conserved in the asexual trophozoite and the
earlier gametocyte stages I-II, as described above, to further
refine our P. falciparum male and female Stage V proteomes
(Pf-M’ and Pf-F’, respectively). We also sought to identify any
potential overlapping proteins that may have partitioned “ar-
tificially” according to the P. berghei PSMA lists but in fact are
nonsex partitioning in P. falciparum and found none (data not
shown).
Comparison of Predicted Functions of Gametocyte Proteins
that Sex-partition in P. berghei and P. falciparum—To identify
potential functional differences in male versus female game-
tocytes based on the proteomics data, we measured enrich-
ment of molecular function based on Gene Ontology (GO)
terms in the male and female protein data sets from both P.
berghei (Fig. 3A) and P. falciparum (Fig. 3H). Indeed we iden-
tified enrichment of GO terms relating to cell motility and
movement as well as microtubule cytoskeleton in the male
gametocyte proteins, reflecting the exflagellation process
during male gamete maturation (Fig. 4A). Conversely, the
FIG. 3. Results from the Systematic Subtractive Protein Bioin-
formatic Approach (SSB). A, Male and Female P. berghei protein
identification following the re-analysis of the published data set (11).
(Refer to Fig. 2) B–G, Detail overlap results from supplemental Fig.
S1A-C. H, Partitioned P. falciparum male- (174) and female- (258)
enriched proteins.
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analysis identified GO term enrichment in female proteins for
RNA binding and processing as well as for protein translation,
relating to the translational repression mechanism that al-
lows for just-in-time protein expression in the female ga-
mete (46). The relevance of other enriched functions such as
particular enzymatic activities in male (kinase, phosphatase)
and female gametocyte proteins (transferase, isomerase,
and oxidoreductase) remains to be determined.
FIG. 4. Analyses of GO molecular function and signatures of selection in male and female P. falciparum proteins. A, Enrichment
analysis of GO molecular function terms in Plasmodium berghei and Plasmodium falciparum. Z-scores are shown as representation of
enrichment, color coded as the key in top left corner. Histogram shows general distribution of enrichments across all samples. Histograms
along columns show exact enrichment amounts. Column normalization for total proteins detected was performed by calculating total number
of GO terms divided by total proteins detected. For simplicity, GO terms were reduced to 22 categories and enrichment calculated over these.
B, Genetic diversity within a parasite population is represented by PiN across 25 parasite isolates from Senegal and divergence between
parasite populations is represented by Fst when comparing the Senegalese isolates with a set of parasite strains from Papua New Guinea
(PNG). Several as yet uncharacterized sex-specific genes (i.e. PF3D7_1430800 and PF3D7_0131600) show high levels of divergence
suggesting that they are under strong diversifying selection.
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Signatures of Natural Selection in Male and Female Game-
tocyte Proteins—All the major transmission blocking vaccine
candidates are not exposed to the human immune system
during in viable gametocytes: Pfs25 is not expressed as a
protein until gamete formation and others such as P47 and
P230 are present on the gametocyte surface before gamete
formation. Most gametocytes are cleared though and not
taken up by a mosquito and thereby able to induce transmis-
sion-reducing immunity in human populations. P47 has an
important role in immune evasion that contributes to the dif-
ferential susceptibility of Anopheles gambiae M and S strains
to P. falciparum infection (47). The immunomodulatory role of
P47 is reflected in unusual population structure with fixed
genetic differences between African and non-African parasite
populations (48, 49). Likewise, we anticipated that Stage V
gametocyte proteins that are either exposed on the infected
RBC surface or on the gamete surface would show signatures
of selection. To systematically test for signatures of natural
selection in the genes encoding the sets of male and female P.
falciparum gametocyte proteins identified in our study, we
determined the rate of single nucleotide polymorphisms
(SNPs) within a parasite population in Senegal (West Africa),
and between this West African parasite population and a
population from Papua New Guinea (48) (supplemental Table
S5, Fig. 4B). As a measure of balancing selection within the
Senegalese population, we calculated SNP  (N) for each
gene based on a sequence comparison of a total of 25 se-
quenced parasite isolates (44). SNP  (N) quantifies the num-
ber of pairwise nonsynonymous differences among the set of
strains analyzed. As a measure for positive selection between
populations, we also calculated Fst (F-statistic or fixation
index) for each gene by comparing the genetic diversity within
the African parasite population with the diversity in the PNG
parasite population. As predicted, P47 showed one of the
highest Fst levels among all the male and female proteins (Fig.
4B). Interestingly, the female gametocyte marker and major
vaccine candidate Pfs25 has an even higher value, reflecting
strong positive selection potentially caused by selection of
gamete recognition and compatibility. In addition, several hy-
pothetical proteins are encoded by genes with high Fst such
as the male-enriched gene PF3D7_1430800 and the female-
enriched gene PF3D7_1358400. Except for one gene encod-
ing a conserved hypothetical male protein PF3D7_0313600,
the sex-partitioned gene set shows significantly lower diver-
sity within the African population than known markers of
balancing selection such as MSP1 or SERA5. This would
suggest that none of the male and female-enriched proteins
described here are subject to selection by their interaction
with the human immune system, either because these pro-
teins are not present on the infected RBC surface or because
of their low abundance during human infection.
Identification of P. falciparum-enriched Gametocyte Sex-
partitioned Proteomes—Once we had assembled the male-
and female-enriched protein lists based on conservation with
P. berghei, we sought to determine if we can derive, through
the SSB approach, the P. falciparum-specific sex partitioned
protein lists. We first performed a principal components anal-
ysis (PCA) using male and female-enriched P. falciparum
stage V proteomes (Pf-M and Pf-F, respectively), replicate
Dd2 and NF54 stage V gametocyte proteomes, as well as
FSgV and FSgI-II protein lists (Fig. 5A). As expected the PCA
demonstrated a clear enrichment for stage V proteins in NF54.
To derive the putative male-enriched stage V protein list, we
compared the NF54-enriched male list (443 proteins, supple-
mental Table S3J) with the FS Asx protein list and identified
354 proteins that likely represent the nonconserved falci-
parum-enriched male proteome (supplemental Table S6A,
Fig. 5B). To derive the putative female-specific stage V protein
list, we first removed 573 proteins that are shared between
Dd2FE/NF54-SP (864 proteins) and the ANKA Male-Female
Common (762 proteins, supplemental Table S2C) protein lists.
This step was effective in filtering out proteins that would still
be present in the Dd2-FE/NF54-SP list and that are conserved
between falciparum and berghei. From this P. falciparum fe-
male-enriched protein list (291 proteins, supplemental Table
S6B, Fig. 5C), we filtered out proteins that are also found in
the FS Asx (1345 proteins) set to identify 177 gametocyte-
enriched female proteins (supplemental Table S6C). We were
cognizant that the FS Asx data set may not have captured all
the late trophozoite or schizont proteins that may be present
in our samples, because GlcNAc treatment does not remove
completely all persisting asexual stages from a gametocyte
culture. These “missed” asexual proteins are highlighted in
the respective male and female lists (supplemental Tables
S6A and S6C). Annotation of proteins to be asexual-specific in
current P. falciparum genome remain simply predictions based
on earlier proteomics studies. It is possible that the annotated
asexual proteins are in fact shared with gametocyte stages.
These proteins may be expressed in mature stages or represent
relic proteins that are expressed in early gametocyte stages but
persist in stage V gametocytes. However, confirming this
“shared” attribute falls outside the scope of the current study.
Considering the presence of such putative merozoite/schizont
proteins, we assembled a conservative list of 339male- and 174
female stage V gametocyte-enriched proteins.
We further determined the degree of NF54 stage V speci-
ficity of proteins to stage V gametocytes by comparing DTgV
with the FS Asx protein lists and noted that 860 proteins were
conserved (Fig. 5D). These 860 proteins comprise 50% of the
total DTgV proteome, and may represent proteins that are
simply conserved between trophozoites and stage V game-
tocytes. Although possible, it is unlikely that these are con-
taminating asexual proteins that are simply present in the
culture, especially following treatment with GlcNAc. Of the
remaining 843 proteins from DTgV (supplemental Table S6D),
216 proteins were found to be conserved in the FSgI-II data
set (supplemental Table S6E), indicating that these proteins
are expressed early in gametocytogenesis and likely remain
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present in stage V gametocytes, given the apparent absence
of stage I-II in the culture, as determined by microscopy (see
above). In our collective experience, the lack of gametocyte
stages I-II is a direct indication of the complete absence of
asexual stages. The remaining 627 proteins that did not
match with either the FS Asx or FSgI-II data sets, represents a
potential pool of stage III-IV gametocyte markers in addition
to those that are present in stage V (supplemental Table S6F).
Of these 627 proteins, 422 proteins (67%) were identified in
the membrane fraction and supported by GO predictions for
cellular component and biological process. Of the 627, 188
proteins (30%) have predicted transmembrane domains and
52% (325/627 proteins) of which are conserved hypothetical
proteins. Several proteins that have been described previ-
ously appear in this putative list of Stage III-V markers, includ-
ing four LCCL domain-containing proteins CCp2 (PF3D7_
1455800), CCp3 (PF3D7_1407000), CCp5 (PF3D7_0109100),
and FNPA (PF3D7_1451600), which all have hypothesized
adhesive functions (40). CCp3 and CCp5 were found to be
female-enriched proteins in our analyses. The NIMA related
kinases, NEK2 (PF3D7_0525900) and NEK4 (PF3D7_
0719200) are also found in this list and categorized as female-
specific proteins as well. There are 95 male-enriched proteins
present in this list, including the two dynein heavy chain
proteins (PF3D7_1122900 and PF3D7_0905300). This short
list of proteins represents a pool of targets that may be used
to select specifically stage III gametocytes from culture.
Identification of the Stage-enriched Male/Female Protein
Markers as Indicators for Stage Transition and to Investigate
the Stage-enriched Dd2 Defect—Since Dd2 is defective in the
production of mature, stage V male gametocytes (35), we
hypothesized that the Dd2 proteome is more enriched pro-
portionately in stage I-II markers, representing the small sub-
set of rectangular and tear-drop forms that we had described
from the Dd2 culture (Table II). Following PCA analysis, we
observed that Dd2 clustered with gametocyte stages I-II pro-
teins, which likely reflects the arrested male gametocytes in
this strain. Moreover, the male- and female-enriched stage V
proteomes appear to be distinct from all other clusters. The
PCA also shows biological reproducibility of our proteome, as
NF54 and Dd2 replicates cluster clearly.
To identify the putative arrest of male gametocytes in Dd2
candidate male protein markers, we also sought to further
narrow the Dd2 stage V gametocyte data set into stage-
specific proteins, and thus compared the Dd2 gametocyte
stage V proteome (1337 proteins), referred to as Dd2gV, with
the FS Asx and FSgI-II data sets. We noted that 804 proteins
were conserved between FS Asx and Dd2gV data sets (Fig.
5F, supplemental Table S7A). Of these, 603 Dd2 trophozoite-
conserved proteins are also found in the NF54 trophozoite-
conserved subset (supplemental Table S7B). These 603 pro-
teins comprise 56% of the total Dd2gV proteome, and may
similarly represent proteins that are conserved between tro-
phozoite and stage V gametocytes, or contaminating proteins
FIG. 5. Principal components analysis (PCA) and SSB analyses
for the identification of P. falciparummale-enriched proteins that
are lost as a result of the Dd2 male development defect. A, PCA
was performed on male- and female-enriched P. falciparum stage V
proteomes (Pf-M and Pf-F, respectively), two biological replicates
(BR1 and BR2) from Dd2, three biological replicates (BR1–3) from
NF54, FSgV (3D7/NF54 stage V), and FSg I-II (3D7/NF54 stages I-II).
Proteins with at least 10 spectral counts averaged across all pro-
teomes were used for qualitative protein analysis. B–C, Stage-spe-
cific analyses identified 354 putative P. falciparum- male- B, and 177
female- C, enriched gametocyte proteins. (D–G) Stage-specific anal-
ysis using published data sets (8) identifies 843 gametocyte-specific
proteins in the NF54 proteome D, of which 216 are also present in
FSg I-II and 627 are only expressed in more mature gametocyte
stages E. The same analysis for Dd2 identifies 533 gametocyte-
specific proteins F, of which 189 are present in FSg I-II, whereas 344
are only expressed in Stage III and later G. H–I, Stage-specificity of
male and female-enriched Dd2 proteins reveals limited overlap be-
tween FSg I-II and conserved, male-enriched P. falciparum proteins H.
However, we noted significant overlap between Dd2 Stage III-V and
P. falciparum-enriched female proteins I.
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that remain present in the GlcNAc-treated culture. Of the
remaining 533 proteins from Dd2gV, 189 proteins were found
in the FSgI-II data set as well (Fig. 5C, supplemental Table
S7C), indicating that these proteins are expressed early in
gametocytogenesis and remain present on female stage V
gametocytes. For Dd2, we found 344 proteins that are stage
V-enriched (supplemental Table S7D). Of these stage V pro-
teins, 227 proteins (66%, 227/344) were identified in the mem-
brane fraction, 62% (142/227 proteins) are conserved hypo-
thetical proteins with diverse predicted GO functions, and
89% (127/142) of these proteins have predicted transmem-
brane domains.
Because Dd2 is defective in producing morphologically
distinct stage V males, we examined whether the 189 Dd2
proteins shared with FSgI-II are enriched in male gametocytes
(Fig. 5H). We found that only 12 proteins were common be-
tween the Pf-M protein list (174 proteins) and the Dd2gI-II set
(supplemental Table S7E). These 12 proteins are also shared
between the Pf-M and NF54-SP protein list (supplemental
Table S3J), which is potentially male-enriched, and the
Dd2gI-II set (data not shown). Of these 12 proteins, two pro-
teins PF3D7_0508200 and PF3D7_1215100 had correspond-
ing transcript markers for immature gametocytes (50), and
were also thus absent from the stage V-enriched Pf-M’ pro-
tein list (109 proteins, supplemental Table S4C). As expected,
46 proteins were found in Dd2gI-II list that are orthologs of
proteins that were shared between males and females in P.
berghei (supplemental Table S7F). Twelve of these proteins
have 2-fold (or greater) enrichment in males in P. berghei.
Although we cannot be certain that the same fold-enrichment
exists for falciparum, based on these analyses, only 24/189
(13%) of the Dd2gI-II proteins are male; suggesting no enrich-
ment of male partitioned proteins. This is not unexpected
given that the 162 remaining Pf-M proteins may be expressed
only at stage III or IV during gametocytogenesis.
We also examined whether the 344 Dd2 proteins that are
candidates for Stage III-V are enriched in female proteins (Fig.
5I). To test this hypothesis we looked for proteins in the Dd2gV
stage-V -enriched protein list that are also found in the Pf-F
(291 P. falciparum female-enriched proteins) list that we had
generated previously, which we then refined to only stage
V-enriched female proteins, Pf-F’ (81 proteins). We observed
that 28 proteins (supplemental Table S7G) were not found in
the Dd2gV stage-V-enriched protein list, and 53 proteins were
conserved (supplemental Table S7H), suggesting that only
15% (53/344) of the Dd2gIII-V-enriched protein list were in the
combined Dd2/NF54 Female protein list (supplemental Table
S6B). It is possible that the number of mature stage V females
in Dd2 with the full protein complement is low; falling below
the identification criteria threshold used in this study. There
are 113 proteins that are shared between Dd2/NF54-SP fe-
males and Dd2 (supplemental Table S7I), which gives a total
of 164 female-enriched proteins in the Dd2gIII-V list. The lack
of enrichment in female proteins in this list may suggest that
a significant proportion of the 178 Dd2gIII-V proteins (supple-
mental Table S7J) are male-female shared proteins or stage III
males. In fact, only 26/178 (15%) of these proteins have
orthologs in the PSMA (P. berghei) male-female shared pro-
tein list. Moreover, expanding the Pf-Female protein list to
include those that are not stage V-enriched (to capture puta-
tive stage III-IV proteins) does not result in additional “female
hits” in the Dd2gIII-V list (supplemental Fig. S2A). Moreover, of
the 291 proteins that remain partitioned to Dd2gIII-V, only 10%
(30/291) have orthologs in the male-female shared protein list.
Assuming that the developmental defect in Dd2 extends be-
yond the presence of mature males and also results in slower
maturation of females, the 178 Dd2/NF54-SP female proteins
may represent the remaining complement of mature stage V
proteins (supplemental Table S7K).
A comparison of the Dd2gV stage-V-enriched protein list
with the Pf-M (P. falciparum male-enriched) protein list iden-
tified 40 conserved proteins (supplemental Fig. S2B, supple-
mental Table S7L), which may include stage III male candidate
markers. We found that two conserved proteins of unknown
function, PF3D7_1413200 and PF3D7_1235800, had corre-
sponding stage-specific transcript markers for immature ga-
metocytes, that is, stages II-IV (31) and another conserved
protein, PF3D7_1404200 had a corresponding mature (stage
V) gametocyte transcript marker. The remaining 69 proteins
(supplemental Table S7M) may represent a pool of candidate
stage IV-V male gametocyte markers. Indeed, we found that
of the 10 proteins with corresponding stage-specific-enriched
transcript markers, five were mature stage V gametocyte pro-
teins, and three corresponded to young (stage I) or immature
(II-IV) gametocytes. Two of the 10 proteins were predicted to
be ring-stage specific, which are likely contaminants in the
sample and the last protein did not have a predicted profile
that was captured by the defined stages used in the Joice et
al. (2013) study (50).
Sex Partitioning for a Subset of Putative Female Protein
Markers is not Conserved between P. berghei and P. falci-
parum—We successfully generated mouse antibodies to
three proteins (PF3D7_1218800; PF3D7_0906100; PF3D7_
0309100). PF3D7_1218800, and PF3D7_0309100 were se-
lected based on their predicted female-specificity using the
ANKA male and female proteomes (supplemental Table S3).
PF3D7_0906100 was also selected because it appeared to be
female-partitioning in P. berghei. However, it was also found
in the P. falciparum 3D7/NF54 Trophozoite (8) and Stage I-II
gametocytes (8) and “Dd2-alone” stage V protein list. We
tested the stage specificity of these antibodies by staining
NF54 male and female gametocytes taken (Fig. 6) and noted
that antibodies for all three proteins stained fully “falciform”
stage V gametocytes from day 17 cultures. Interestingly,
PF3D7_0309100 appears to differentiate falciform from stage
IV-V transitioning gametocytes, i.e. elongated gametocytes,
from those gametocytes with more pronounced curvature but
not completely falciform (indicated as V and V’ stages in Fig.
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6) (51). The antibodies were further validated by Western blot
analysis to assess stage specificity (Fig. 7A). We found that
the anti-PF3D7_0906100 antibodies recognized a 28 kDa
protein band (predicted Mr  21.9 kDa) in both day 17 game-
tocyte and synchronized trophozoite lysates from NF54 and
Dd2. However, the staining intensity appeared to be more
pronounced for NF54 gametocytes and less so for Dd2 tro-
phozoites. Anti-PF3D7_1218800 antibodies recognized a
37 kDa protein band (predicted Mr  39.6 kDa) and a lower
Mr protein band around 26 kDa in NF54 and Dd2 gametocytes
only. However, the antibodies also recognized a similar lower
Mr band, 26 kDa in the Dd2 trophozoite sample. The exact
nature and identity of this protein band is not clear at present,
but given the developmental defect in Dd2 during gametocy-
togenesis, we cannot rule out the possibility of dysregulated
protein expression in the asexual stages of Dd2. Moreover,
we cannot completely rule out the presence of stage I/II
gametocytes in the sample, although none were observed by
microscopy and PF3D7_1218800 was not found in the FsgI-II
protein list. Anti-PF3D7_0309100 antibodies appear to be
highly specific to gametocytes in both NF54 and Dd2.
We further determined sex-specific staining by the antibod-
ies using the morphological characteristics of male and fe-
male gametocytes (35) along with strong DAPI costaining of
DNA (Fig. 7B–7C). Of the three antisera tested, only two
(PF3D7_1218800 and PF3D7_0906100) were found to be fe-
male-specific by fluorescence microscopy for both NF54 (Fig.
7B) and Dd2 (Fig. 7C), sex-partitioning that is conserved
between P. berghei and P. falciparum. We also consistently
noted that Dd2 female stage V gametocytes appeared more
bulbous as compared with NF54. PF3D7_0906100 also re-
ferred to as a putative Developmental Protein partitioned ini-
tially with the female-enriched protein list. However, because
we had identified it in both our Dd2 stage V gametocyte
FIG. 6. Immunofluorescence analysis of antibodies elicited against putative male- and female-enriched gametocyte stage V proteins.
Antibodies were raised in mouse against PF3D7_1218800, PF3D7_0390100 and PF3D7_0906100. The lower panel is a cartoon depicting the
various stages of NF54 gametocyte development, especially stages IV and V, which we have observed as the primary stage present in a day
18 gametocyte culture. Gametocytes that are labeled V’ are considered mature stage V parasites, and those labeled V, are considered
complete “falciform” (crescent) shaped stage V gametocytes. EB, Evans blue counter stain for protein, and appear red. GV (gametocyte stage
V marker antibodies) are detected with Alexa488-conjugated secondary antibodies and appear green. DAPI stains DNA and appears blue.
Scale bar  10 m.
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(Dd2gV) protein list and the Trophozoite (FS Asx) protein list
(8), we did not include this protein in the stage V-enriched
male and female protein lists. Although the ortholog in P.
berghei (PBANKA_041520) was included in the female-en-
riched protein list for P. berghei, a close examination of the
spectral data revealed that it was identified by a single
peptide only in a single replicate batch of purified females
(supplemental Table S2E). It is likely that this protein exists
in both males and females in P. berghei. Antibodies to
PF3D7_0309100, which is found in the putative female-
enriched “NF54-Dd2 Common Proteins” list (supplemental
Table S1C), surprisingly stained both males and females
(Fig. 7B–7C). We also observed several examples of anti-
body labeling of Dd2 (day 17) gametocyte that is in essence
rectangular or cuboidal (Fig. 7C). These rectangular/cuboi-
dal and teardrop (data not shown) forms exhibit a DNA stain
distribution indicative of a male form. PF3D7_0309100 was
detected in FSgI-II and FSgV protein lists (8), suggesting that
Dd2 male gametocyte maturation reaches stage II but ar-
rests prior to progression to stage III.
DISCUSSION
One of the major caveats of the SSB approach is that the
analysis is limited by the proteome size and accuracy of
categorization. We recognized, a priori, that we are likely to
miss out on a few potential male or female proteins, as we had
noted in the comparison of our data set with the previously
published, FSgV mixed-sex proteome. However, it is also
clear that given the differential efficiencies in proteome acqui-
sition across MS approaches, the community must consider
FIG. 7.Western blots and immunohistochemistry using NF54 and Dd2 strains validate female stage V gametocyte specificity for two
of three candidate protein markers. A, Western blots of total day 17 stage V gametocyte and synchronized trophozoite protein lysates using
the respective antibodies along with anti-P. falciparum aldolase antibodies used as a loading control. Western blots showed that
PF3D7_1218800 and PF3D7_0309100 were present in female gametocytes (Dd2 is defective in mature male gametocyte development),
yielding bands in gametocyte but not trophozoite samples for both NF54 and Dd2. Antibodies to PF3D7_0906100 stain gametocytes and
trophozoites from NF54 but primarily stains Dd2 gametocytes. B, Representative results for fluorescence immunohistochemistry of strain
NF54. PF3D7_1218800 and PF3D7_0906100 were found to be female-specific (green). PF3D7_0309100, which is an ortholog of a putative
female-specific protein in P. berghei is not sex-specific in P. falciparum. C, Representative results for fluorescence immunohistochemistry of
strain Dd2. PF3D7_1218800, PF3D7_0906100, and PF3D7_0309100 were all found to stain female parasites (green), as Dd2 fail to produce
mature stage V male gametocytes. Parasite sex was microscopically determined using published morphological characteristics of male and
female gametocytes (35, 55) or spatially distinct DAPI staining (blue) of DNA. Female gametocytes have condensed DAPI staining whereas male
gametocytes have diffused DAPI staining (35, 55). Isotype control antibody staining of mature stage V female gametocytes for both Dd2 and
NF54 are shown in the lower right set of panels.
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using the combined databases in their proteome mining stud-
ies for proteins of interest. For example, we were able to
corroborate the identification of the non-(sex) partitioning,
PIESP2 (PF3D7_0501200) in stage I-II and stage V gameto-
cytes. It is a putative exported parasite-infected erythrocyte
surface protein, with a predicted PEXEL motif, in stage V
gametocytes. PIESP2 was notable in that transcript for this
protein is virtually absent in stages I-II and stage V gameto-
cytes (PlasmoDB) and it was also found to be potentially on
the RBC membrane surface in asexuals (52) and during liver
stage development (53).
We had also observed the consistent partitioning of Dd2-
enriched proteins following our comparisons with the NF54
(DTgV) and the 3D7/NF54 (FSgV) stage V proteomes. Pro-
teomic analyses of Dd2 has not been performed to date, but
this observed partitioning is really unexpected as we would
expect that the differences in gene content between the two
P. falciparum strains should probably be minimal. Although
we have begun a partial analysis of the Dd2 developmental
defect by identifying the enrichment and expression of
stage and male-partitioned proteins by SSB and fluores-
cence microscopy, the morphological differences observed
even for the mature female Dd2 gametocytes suggest that
the defect may also result in dysregulated expression of
proteins that would not normally be present during “normal”
gametocytogenesis.
From a translational perspective, we have provided sex-
partitioned information for several stagespecific gameto-
cyte transcript markers (51) that can be used to analyze
blood samples taken during surveillance studies in malaria
endemic countries. In the same vein, the antibodies that we
have generated in this study may ultimately represent novel
diagnostic markers for gametocyte carriage in the blood or
other body fluid (e.g. urine or saliva) of infected but asymp-
tomatic individuals. PF3D7_0906100 (conserved hypotheti-
cal protein), PF3D7_0309100 (a putive development gene),
and PF3D7_1218800 (putative secreted ookinete protein,
PSOP17) have not been well characterized to date. Previous
attempts to knock out PSOP17 in P. berghei were unsuc-
cessful and highlight the importance of this protein in par-
asite development in the asexual blood stages as well (54).
The complete characterization of each of these proteins is
the focus of current efforts in our laboratories, as they have
potential as new transmission-blocking vaccine targets
and/or sex-enriched biomarkers of gametocyte carriage.
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